Sound View Wealth Advisors Group, LLC Krystal Biotech, Inc. Transaction History
Sound View Wealth Advisors Group, LLC
- $1.47 Billion
- Q4 2025
A detailed history of Sound View Wealth Advisors Group, LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Sound View Wealth Advisors Group, LLC holds 1,579 shares of KRYS stock, worth $325,526. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,579
Previous 2,003
21.17%
Holding current value
$325,526
Previous $353,000
7.93%
% of portfolio
0.02%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding KRYS
# of Institutions
325Shares Held
25.1MCall Options Held
241KPut Options Held
625K-
Black Rock Inc. New York, NY3.95MShares$814 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.79MShares$576 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.78MShares$573 Million6.7% of portfolio
-
State Street Corp Boston, MA1.4MShares$288 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT1.02MShares$210 Million10.94% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $5.29B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...